Tom Vulliamy

13.0k total citations · 2 hit papers
111 papers, 8.2k citations indexed

About

Tom Vulliamy is a scholar working on Physiology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tom Vulliamy has authored 111 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Physiology, 47 papers in Molecular Biology and 36 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tom Vulliamy's work include Telomeres, Telomerase, and Senescence (44 papers), Neonatal Health and Biochemistry (34 papers) and DNA Repair Mechanisms (15 papers). Tom Vulliamy is often cited by papers focused on Telomeres, Telomerase, and Senescence (44 papers), Neonatal Health and Biochemistry (34 papers) and DNA Repair Mechanisms (15 papers). Tom Vulliamy collaborates with scholars based in United Kingdom, United States and Germany. Tom Vulliamy's co-authors include Inderjeet Dokal, Philip J. Mason, Anna Marrone, Amanda J. Walne, S. W. Knight, Lucio Luzzatto, Michael Kirwan, Richard Beswick, Monica Bessler and Ernest Beutler and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Tom Vulliamy

110 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions

1998 708 citations S. W. Knight, Tom Vulliamy et al. profile →
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita

2001 705 citations Tom Vulliamy, Anna Marrone et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Vulliamy United Kingdom	48	4.2k	3.9k	1.6k	1.2k	982	111	8.2k
Rodrigo T. Calado Brazil	36	2.6k 0.6×	1.9k 0.5×	291 0.2×	586 0.5×	486 0.5×	191	6.3k
Paul‐Henri Roméo France	52	941 0.2×	4.6k 1.2×	523 0.3×	654 0.5×	610 0.6×	151	7.7k
Bernard Grandchamp France	58	741 0.2×	5.8k 1.5×	1.6k 1.0×	833 0.7×	1.2k 1.2×	228	11.5k
Wim J. Kleijer Netherlands	39	2.9k 0.7×	3.6k 0.9×	328 0.2×	678 0.6×	226 0.2×	137	7.0k
Punam Malik United States	39	641 0.2×	2.3k 0.6×	415 0.3×	1.1k 0.9×	354 0.4×	138	4.7k
Willy Lissens Belgium	43	625 0.1×	3.3k 0.8×	1.3k 0.8×	1.8k 1.5×	926 0.9×	235	7.0k
Mary Armanios United States	42	3.9k 0.9×	2.4k 0.6×	133 0.1×	477 0.4×	2.6k 2.7×	67	7.1k
Bertil Glader United States	30	674 0.2×	2.2k 0.5×	365 0.2×	1.6k 1.3×	239 0.2×	131	4.6k
Melvin H. Freedman Canada	35	552 0.1×	1.6k 0.4×	449 0.3×	1.6k 1.3×	322 0.3×	140	6.0k
David H.K. Chui United States	41	1.2k 0.3×	2.0k 0.5×	1.7k 1.1×	814 0.7×	263 0.3×	225	6.7k

Countries citing papers authored by Tom Vulliamy

Since Specialization

Citations

This map shows the geographic impact of Tom Vulliamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Vulliamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Vulliamy more than expected).

Fields of papers citing papers by Tom Vulliamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Vulliamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Vulliamy. The network helps show where Tom Vulliamy may publish in the future.

Co-authorship network of co-authors of Tom Vulliamy

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Vulliamy. A scholar is included among the top collaborators of Tom Vulliamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Vulliamy. Tom Vulliamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tummala, Hemanth, Amanda J. Walne, Roberto Buccafusca, et al.. (2022). Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita. The American Journal of Human Genetics. 109(8). 1472–1483. 13 indexed citations

Vulliamy, Tom, Inderjeet Dokal, Jean Soulier, et al.. (2021). Multinational Study on the Clinical and Genetic Features of the ERCC6L2-Disease. Blood. 138(Supplement 1). 864–864. 1 indexed citations

Tummala, Hemanth, Amanda J. Walne, Findlay Bewicke‐Copley, et al.. (2020). A frameshift variant in specificity protein 1 triggers superactivation of Sp1-mediated transcription in familial bone marrow failure. Proceedings of the National Academy of Sciences. 117(29). 17151–17155. 4 indexed citations

Jongmans, Marjolijn C.J., Eugène T.P. Verwiel, Yvonne F. Heijdra, et al.. (2012). Revertant Somatic Mosaicism by Mitotic Recombination in Dyskeratosis Congenita. The American Journal of Human Genetics. 90(3). 426–433. 74 indexed citations

Blaydon, Diana C., Paolo Biancheri, Wei‐Li Di, et al.. (2011). Inflammatory Skin and Bowel Disease Linked toADAM17Deletion. New England Journal of Medicine. 365(16). 1502–1508. 235 indexed citations

Kirwan, Michael, Richard Beswick, Amanda J. Walne, et al.. (2011). Dyskeratosis congenita and the DNA damage response. British Journal of Haematology. 153(5). 634–643. 26 indexed citations

Mortazavi, Yousef, et al.. (2010). Glucose 6-phosphate dehydrogenase deficiency in Tehran, Zanjan and Sistan-Balouchestan provinces: prevalence and frequency of Mediterranean variant of G6PD. Iranian Journal of Biotechnology. 8(4). 22–233. 7 indexed citations

Vulliamy, Tom, Richard Beswick, Michael Kirwan, et al.. (2008). Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proceedings of the National Academy of Sciences. 105(23). 8073–8078. 235 indexed citations

Kirwan, Michael, Richard Beswick, Tom Vulliamy, et al.. (2008). Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. British Journal of Haematology. 144(5). 771–781. 29 indexed citations

10.

Barišić, Marin, et al.. (2005). Characterization of G6PD deficiency in southern Croatia: description of a new variant, G6PD Split. Journal of Human Genetics. 50(11). 547–549. 11 indexed citations

11.

Keith, W. Nicol, Tom Vulliamy, Jiangqin Zhao, et al.. (2004). A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. PubMed. 4(1). 3–3. 28 indexed citations

12.

He, Jun, et al.. (2002). Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene. 21(50). 7740–7744. 77 indexed citations

13.

Vulliamy, Tom, Anna Marrone, Frederick D. Goldman, et al.. (2001). The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 413(6854). 432–435. 705 indexed citations breakdown →

14.

Amrolia, Persis, Tom Vulliamy, George S. Vassiliou, et al.. (2001). Analysis of chimaerism in thalassaemic children undergoing stem cell transplantation. British Journal of Haematology. 114(1). 219–225. 18 indexed citations

15.

Mason, Philip J., et al.. (1999). Human Hexose-6-phosphate Dehydrogenase (Glucose 1-Dehydrogenase) Encoded at 1p36: Coding Sequence and Expression. Blood Cells Molecules and Diseases. 25(1). 30–37. 45 indexed citations

16.

Spencer, Andrew, et al.. (1997). Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia. Leukemia. 11(2). 195–201. 6 indexed citations

17.

Ganczakowski, Mary, M Town, D. K. Bowden, et al.. (1995). Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific).. Europe PMC (PubMed Central). 56(1). 294–301. 72 indexed citations

18.

Ahluwalia, Amrita, Tom Vulliamy, Chandramohan S. Ishwad, et al.. (1992). G6PD Kalyan and G6PD Kerala; two deficient variants in India caused by the same 317 Glu↑Lys mutation. Human Molecular Genetics. 1(3). 209–210. 18 indexed citations

19.

Calabrò, Viola, et al.. (1992). Molecular heterogeneity underlying the G6PD Mediterranean phenotype. Human Genetics. 88(6). 688–690. 38 indexed citations

20.

Mason, Philip J., et al.. (1988). The production of normal and variant human glucose‐6‐phosphate dehydrogenase in cos cells. European Journal of Biochemistry. 178(1). 109–113. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact